Literature DB >> 15483077

The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.

Sau-Cheung Tiu1, Cheung-Hei Choi, Chi-Chung Shek, Ying-Wai Ng, Fredriech K W Chan, Chiu-Ming Ng, Alice P S Kong.   

Abstract

Recent reviews recommended the use of the aldosterone/renin ratio (ARR) to screen for primary hyperaldosteronism. However, widely different cutoff levels have been proposed, and test characteristics of ARR under different conditions of sampling are not known. We conducted a retrospective review among 45 subjects with carefully validated diagnoses of primary hyperaldosteronism and 17 subjects with essential hypertension to study the utility of ARR. Sixty-two patients with 75 sets of plasma renin activity (PRA), aldosterone, and ARR values from a postural study and 48 sets of values from a saline suppression test were analyzed. Ninety-four percent of these subjects underwent investigations because of hypokalemic hypertension.ARR yielded larger areas under the curve in the receiver-operating-characteristics curve than PRA or aldosterone under all conditions of testing. Our results confirmed the superiority of ARR to either aldosterone or PRA alone as a diagnostic test for primary hyperaldosteronism.ARR cutoff levels were significantly affected by the condition of testing. Depending on posture and time of day, it varied from 13.1-35.0 ng/dl per ng/ml.h in our study population. When using ARR for screening primary hyperaldosteronism, posture and time of sampling should be standardized both within and between centers to minimize variability in cutoff levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483077     DOI: 10.1210/jc.2004-1149

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.

Authors:  F Pizzolo; G Salvagno; B Caruso; C Cocco; F Zorzi; C Zaltron; A Castagna; L Bertolone; F Morandini; G Lippi; O Olivieri
Journal:  J Hum Hypertens       Date:  2017-08-24       Impact factor: 3.012

Review 4.  Primary aldosteronism is a public health issue: challenges and opportunities.

Authors:  Renata Libianto; Peter J Fuller; Morag J Young; Jun Yang
Journal:  J Hum Hypertens       Date:  2020-04-27       Impact factor: 3.012

5.  Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.

Authors:  Ryo Morimoto; Yoshikiyo Ono; Yuta Tezuka; Masataka Kudo; Sachiko Yamamoto; Toshiaki Arai; Celso E Gomez-Sanchez; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

6.  Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism.

Authors:  Evelyn Fischer; Felix Beuschlein; Martin Bidlingmaier; Martin Reincke
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

7.  Adrenal venous sampling for stratifying patients for surgery of adrenal nodules detected using dynamic contrast enhanced CT.

Authors:  Jin Young Kim; See Hyung Kim; Hee Jung Lee; Young Hwan Kim; Mi Jeong Kim; Seung Hyun Cho
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

Review 8.  Primary Aldosteronism: a Continuum from Normotension to Hypertension.

Authors:  Taweesak Wannachalee; Adina F Turcu
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

9.  Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Authors:  Sabine C Käyser; Jaap Deinum; Wim Jc de Grauw; Bianca Wm Schalk; Hans Jhj Bor; Jacques Wm Lenders; Tjard R Schermer; Marion Cj Biermans
Journal:  Br J Gen Pract       Date:  2018-01-15       Impact factor: 5.386

10.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.